Covidien to Acquire Minimally Invasive Interventional Pulmonology Devices Developer for $300M

Covidien has announced it has reached a definitive agreement to acquire superDimension, a developer of minimally invasive interventional pulmonology devices based in Israel, according to a news release.

Advertisement

 

superDimension’s i-Logic System uses Electromagnetic Navigation Bronchoscopy to provide minimally invasive access to lesions in the lungs as well as mediastinal lymph nodes.

 

Covidien will acquire all of the outstanding capital stock of superDimension for approximately $300 million. The transaction is expected to be completed in the second calendar quarter of 2012.

 

Related Articles on Company Acquisitions:

GE Healthcare to Acquire Biopharmaceutical Manufacturer Xcellerex

ZOLL Medical to be Acquired by Tokyo’s Asahi Kasei for $2.2B

Boston Scientific to Acquire Cameron Health

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.